The board of directors of healthcare company Abbott (NYSE:ABT) approved a quarterly dividend of USD0.36 per share of the company's common stock, it declared on Friday.
In addition, the company has increased its dividend payout for 48 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.
This cash dividend is due on 15 May 2020 to shareholders of record at the close of business as of 15 April 2020.
Abbott said its portfolio of life-changing technologies covers all healthcare, with businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project